Pfizer (PFE) and Bristol-Meyers (BMY) win FDA approval for Eliquis
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) and Bristol-Meyers (NYSE: BMY) win FDA approval for Eliquis, according to Bloomberg headlines.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine
- FDA approves Takeda's Mimrylo for rare blood cancer polycythemia vera
- Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
Create E-mail Alert Related Categories
FDA, General NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
